Literature DB >> 28828727

Concurrent assessment of calpain and caspase3 activities in brains of mice with acetaminophen-induced acute hepatic encephalopathy.

Bahareh Shabrang1, Akram Jamshidzadeh2, Mojtaba Farjam3,4, Azin Ebrahimpour5, Omid Koohi-Hosseinabadi6.   

Abstract

To develop pharmacological therapy for acute hepatic encephalopathy (AHE), understanding the molecular basis for cell injury is essential. Excitotoxic neural cell injury mediated by calpain as a post- receptor mechanism has been proposed as a player in neuronal injury in AHE. Concurrent assessment of Calpain and Caspase3 activities in the brain of AHE mice in acetaminophen- induced mourine model was performed. After induction of AHE by acetaminophen in mice, the model was confirmed by histopathological, biochemical and behavioural studies. The brains were removed, western blot analysis was done and the relative activity of calpain and caspase was estimated and compared to control group calpain but not caspase 3 activity was significantly increased in the AHE group compared to the control brains. Experimentally, this finding is the first to report. Increased calpain activity in liver has been previously reported. To translate both finding it can be suggested that calpain inhibition can be an investigational intervention in saving lives in AHE. To confirm the results, besides more advanced toxicodynamic studies on acetaminophen, the results should be confirmed in other models of AHE in future.

Entities:  

Keywords:  Acetaminophen; Acute hepatic encephalopathy; Calpain; Caspase; Neural cell injury

Mesh:

Substances:

Year:  2017        PMID: 28828727     DOI: 10.1007/s11011-017-0096-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  13 in total

1.  Concurrent assessment of calpain and caspase-3 activity by means of western blots of protease-specific spectrin breakdown products.

Authors:  J K Newcomb; B R Pike; X Zhao; R L Hayes
Journal:  Methods Mol Biol       Date:  2000

Review 2.  Experimental models of hepatic encephalopathy: ISHEN guidelines.

Authors:  Roger F Butterworth; Michael D Norenberg; Vicente Felipo; Peter Ferenci; Jan Albrecht; Andres T Blei
Journal:  Liver Int       Date:  2009-07       Impact factor: 5.828

3.  Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis.

Authors:  V Kohli; J F Madden; R C Bentley; P A Clavien
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

4.  Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.

Authors:  B A Vogels; M A Maas; J Daalhuisen; G Quack; R A Chamuleau
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

5.  Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants.

Authors:  Pallavi B Limaye; Udayan M Apte; Kartik Shankar; Thomas J Bucci; Alan Warbritton; Harihara M Mehendale
Journal:  Toxicol Appl Pharmacol       Date:  2003-09-15       Impact factor: 4.219

Review 6.  Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.

Authors:  Rune Gangsøy Kristiansen; Christopher F Rose; Lars Marius Ytrebø
Journal:  Metab Brain Dis       Date:  2016-06-23       Impact factor: 3.584

7.  Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis.

Authors:  R J de Knegt; S W Schalm; C C van der Rijt; D Fekkes; E Dalm; I Hekking-Weyma
Journal:  J Hepatol       Date:  1994-01       Impact factor: 25.083

8.  Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes.

Authors:  M Farjam; P Dehdab; F Abbassnia; D Mehrabani; N Tanideh; S Pakbaz; M H Imanieh
Journal:  Iran Red Crescent Med J       Date:  2012-03-01       Impact factor: 0.611

9.  Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis.

Authors:  Mojtaba Farjam; Faegheh Baha'addini Beigi Zarandi; Shirin Farjadian; Bita Geramizadeh; Ali Reza Nikseresht; Mohammad Reza Panjehshahin
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 10.  How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.

Authors:  Debbie L Shawcross; Arthur A Dunk; Rajiv Jalan; Gerald Kircheis; Robert J de Knegt; Wim Laleman; John K Ramage; Heiner Wedemeyer; Ian E J Morgan
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-02       Impact factor: 2.566

View more
  1 in total

1.  The Potential Neuroprotective Role of Citicoline in Hepatic Encephalopathy.

Authors:  Omid Farshad; Pedram Keshavarz; Reza Heidari; Mina Farahmandnejad; Sara Azhdari; Akram Jamshidzadeh
Journal:  J Exp Pharmacol       Date:  2020-11-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.